Search

Nanoparticles-based antioxidative therapy has been highlighted in a series of diseases triggered by excessive reactive oxygen species (ROS). Prussian blue nanoparticles (PBNPs), as a representative artificial nanozyme, have been proved as highly effective ROS scavengers. However, its detailed intracellular antioxidant mechanism is not clear yet. Herein, a series of PBNPs with different particle sizes were synthesized and their intracellular antioxidant activities were studied by atomic force microscopy (AFM) from a biomechanical perspective. We first validated the ROS scavenging ability of PBNPs in vitro. It indicated that PBNPs had great scavenging effect on multiple ROS, such as hydroxyl radicals (•OH), superoxide radicals (O 2 •−) and hydrogen peroxide (H 2 O 2). By observing the changes in morphology and mechanical properties of human umbilical vascular endothelium cells (HUVECs), it was further found that PBNPs could apparently alleviate the decrease of Young's modulus caused by oxidative stress damage and kept cells in their normal morphology. In addition, the distribution of F-actin revealed that the enhancement of cytoskeleton stability by PBNPs might be a key way to protect HUVECs from oxidative damage. Importantly, the antioxidant activities of PBNPs were found to be size-dependent, which indicated the smaller particle size had better antioxidant activities compared with the larger particle size. This study serves as a novel medium to reveal the mechanism of nanoparticles on cells at the single-cell level and demonstrates the great potential of atomic force microscopy in studying the application of nanoparticles in cell biology. [Display omitted] • PBNPs with different particle sizes were prepared based on regulated ethanol aqueous solution. • PBNPs had excellent ROS scavenging activity with size dependence. • PBNPs mitigated the shrinkage of cell morphology and the decrease of cell modulus caused by excess ROS. • AFM was utilized as a promising tool for exploring the antioxidant mechanism of nanomaterials. [ABSTRACT FROM AUTHOR]

Immunotherapy has emerged as an effective treatment modality for cancer. The interaction of programmed cell death ligand-1 (PD-L1) and programmed cell death protein-1 (PD-1) plays a key role in tumor-related immune escape and has become one of the most extensive targets for immunotherapy. Herein, we investigated the interaction of PD-L1 with its antibody and PD-1 using atomic force microscopy-based single molecule force spectroscopy for the first time. It was found that the PD-L1/anti-PD-L1 antibody complex was easier to dissociate than PD-L1/PD-1. The unbinding forces of specific interaction of PD-L1 on T24 cells with its antibody and PD-1 were quantitatively measured and similar to those on substrate. In addition, the location of PD-L1 on T24 cells was mapped at the single-molecule level by force-volume mapping. The force maps revealed that PD-L1 randomly distributed on T24 cells surface. The recognition events on cells obviously increased after INF-γ treatment, which proved that INF-γ up-regulated the expression of PD-L1 on T24 cells. These findings enrich our understanding of the molecular mechanisms by which PD-L1 interacts with its antibody and PD-1. It provides useful information for the physical factors that is needed to be considered in the design of inhibitors for tumor immunology. [Display omitted] • The interaction of PD-L1 with its antibody and PD-1 was investigated by AFM. • The distribution of PD-L1 on cells was visualized at the single-molecule level. • The effect of INF-γ on PD-L1 expression on cells was quantitatively characterized. • This work provides new insights into the biophysical properties of PD-L1. [ABSTRACT FROM AUTHOR]